Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Continuing Education

Indium-111 Satumomab Pendetide: The First FDA-Approved Monoclonal Antibody for Tumor Imaging

Paul J. Bohdiewicz
Journal of Nuclear Medicine Technology September 1998, 26 (3) 155-163;
Paul J. Bohdiewicz
Nuclear Medicine Department, William Beaumont Hospital, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 26 no. 3 155-163

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Published online September 1, 1998.

Copyright & Usage 
© 1998 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Paul J. Bohdiewicz
  1. Nuclear Medicine Department, William Beaumont Hospital, Royal Oak, Michigan

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: February 2001 to April 2025

AbstractFullPdf
Feb 2001200
Mar 2001200
Apr 2001400
Aug 2001100
Oct 2001100
Nov 2001100
Dec 2001500
Feb 2002200
Mar 2002100
Apr 2002500
May 2002101
Jul 2002100
Nov 2002100
Jan 2003200
Feb 2003100
Mar 2003100
Apr 2003200
May 2003200
Jun 2003100
Jul 2003800
Aug 2003600
Sep 2003800
Oct 2003400
Nov 2003500
Dec 2003700
Jan 20041500
Feb 2004400
Mar 20041000
Apr 2004900
May 2004700
Jun 2004500
Jul 2004800
Aug 20044200
Sep 20044700
Oct 20042700
Nov 20042700
Dec 20043500
Jan 20052900
Feb 20053000
Mar 20053900
Apr 20054800
May 20051800
Jun 20051000
Jul 2005900
Aug 20051600
Sep 20051300
Oct 20052500
Nov 20052900
Dec 20052600
Jan 20062700
Feb 20061700
Mar 20062600
Apr 20061700
May 20062800
Jun 20061300
Jul 20062100
Aug 20062400
Sep 20061400
Oct 20062400
Nov 20061100
Dec 2006500
Jan 20072301
Feb 20072000
Mar 20074400
Apr 20071900
May 20071600
Jun 20071100
Jul 20071200
Aug 20071500
Sep 2007800
Oct 20071802
Nov 20072500
Dec 20071600
Jan 20085400
Feb 20082100
Mar 20082000
Apr 20082300
May 20081000
Jun 20082600
Jul 20081400
Aug 20081800
Sep 20083200
Oct 20081300
Nov 20081900
Dec 20081700
Jan 20092500
Feb 20093200
Mar 20091500
Apr 20092100
May 20094000
Jun 20092000
Jul 20092900
Aug 20092100
Sep 20091900
Oct 20092500
Nov 20093000
Dec 20092100
Jan 20103400
Feb 20102400
Mar 20102000
Apr 20101000
May 20101700
Jun 2010700
Jul 20102000
Aug 2010800
Sep 20101100
Oct 20101400
Nov 20101600
Dec 20101000
Jan 20111400
Feb 20111400
Mar 20111900
Apr 20111400
May 2011800
Jun 20111500
Jul 2011700
Aug 20111000
Sep 20115400
Oct 20111000
Nov 20111500
Dec 20111100
Jan 20121600
Feb 20121300
Mar 20121400
Apr 20122300
May 20124100
Jun 20121200
Jul 20122000
Aug 20121700
Sep 201211600
Oct 20124300
Nov 20123000
Dec 20123200
Jan 20132700
Feb 20132400
Mar 20132200
Apr 20132700
May 20134000
Jun 2013900
Jul 2013400
Aug 2013400
Sep 20137700
Oct 20132400
Nov 2013200
Dec 2013500
Jan 2014400
Feb 2014500
Mar 2014100
Apr 2014600
May 2014400
Jun 2014100
Jul 2014400
Aug 2014700
Sep 20143600
Oct 20141600
Dec 2014200
Jan 2015401
Feb 2015200
Mar 20151500
Apr 2015500
May 2015500
Jun 2015100
Jul 2015907
Aug 20151907
Sep 201554011
Oct 2015902
Nov 2015205
Dec 2015308
Jan 2016608
Feb 20166016
Mar 20163017
Apr 201610020
May 20164023
Jun 201610018
Jul 20168023
Aug 20165015
Sep 201612015
Oct 201623057
Nov 20166017
Dec 201690024
Jan 201718028
Feb 201713026
Mar 20176037
Apr 20177013
May 20179116
Jun 20178017
Jul 20175029
Aug 20179021
Sep 201710025
Oct 20177058
Nov 201740127
Dec 20178092
Jan 201830151
Feb 201810161
Mar 201890141
Apr 201880132
May 2018150104
Jun 201800100
Jul 20184078
Aug 20181060
Sep 20181053
Oct 20181079
Nov 20182088
Dec 20182047
Jan 20197078
Feb 20194053
Mar 20193082
Apr 20195079
May 20196089
Jun 20191060
Jul 20193080
Aug 20193087
Sep 20192091
Oct 20192051
Nov 201910034
Dec 201919058
Jan 20203032
Feb 20202028
Mar 202011031
Apr 202010046
May 20209032
Jun 20207031
Jul 20202027
Aug 20206027
Sep 20207024
Oct 20206033
Nov 20206027
Dec 20205027
Jan 20214041
Feb 20216042
Mar 20219029
Apr 202114027
May 202110027
Jun 202110082
Jul 202114048
Aug 202116020
Sep 202110021
Oct 20218027
Nov 202121057
Dec 202118047
Jan 202222031
Feb 202222032
Mar 202210053
Apr 202210039
May 20225028
Jun 20223027
Jul 20228033
Aug 20221022
Sep 202213018
Oct 20225022
Nov 20229014
Dec 202212017
Jan 20237030
Feb 20239015
Mar 202318061
Apr 202320028
May 202316033
Jun 202310040
Jul 20239048
Aug 202313031
Sep 20233015
Oct 20234020
Nov 202325026
Dec 202317025
Jan 202411026
Feb 202410030
Mar 20243039
Apr 202422045
May 202433042
Jun 202419024
Jul 202413058
Aug 202423035
Sep 202454060
Oct 202439037
Nov 202433037
Dec 202426035
Jan 202514021
Feb 202537052
Mar 202513024
Apr 202531041
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 26 (3)
Journal of Nuclear Medicine Technology
Vol. 26, Issue 3
September 1, 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Indium-111 Satumomab Pendetide: The First FDA-Approved Monoclonal Antibody for Tumor Imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Indium-111 Satumomab Pendetide: The First FDA-Approved Monoclonal Antibody for Tumor Imaging
Paul J. Bohdiewicz
Journal of Nuclear Medicine Technology Sep 1998, 26 (3) 155-163;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Indium-111 Satumomab Pendetide: The First FDA-Approved Monoclonal Antibody for Tumor Imaging
Paul J. Bohdiewicz
Journal of Nuclear Medicine Technology Sep 1998, 26 (3) 155-163;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Fifty Years of Radiopharmaceuticals
  • Penetratin Improves Tumor Retention of Single-Chain Antibodies: A Novel Step toward Optimization of Radioimmunotherapy of Solid Tumors
  • Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

Keywords

  • indium-111 satumomab pendetide
  • indium-111 OncoScint® CR-OV
  • monoclonal antibody
  • radionuclide tumor imaging
SNMMI

© 2025 SNMMI

Powered by HighWire